Compare Pfizer with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs SUN PHARMA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER SUN PHARMA PFIZER/
SUN PHARMA
 
P/E (TTM) x 33.0 28.3 116.6% View Chart
P/BV x 5.5 2.4 226.4% View Chart
Dividend Yield % 0.6 0.7 94.2%  

Financials

 PFIZER   SUN PHARMA
EQUITY SHARE DATA
    PFIZER
Mar-18
SUN PHARMA
Mar-19
PFIZER/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs2,365679 348.4%   
Low Rs1,625375 432.9%   
Sales per share (Unadj.) Rs430.3121.1 355.2%  
Earnings per share (Unadj.) Rs78.713.4 588.4%  
Cash flow per share (Unadj.) Rs93.220.7 450.5%  
Dividends per share (Unadj.) Rs20.002.75 727.3%  
Dividend yield (eoy) %1.00.5 192.2%  
Book value per share (Unadj.) Rs586.5172.6 339.8%  
Shares outstanding (eoy) m45.752,399.26 1.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.64.4 106.6%   
Avg P/E ratio x25.339.4 64.3%  
P/CF ratio (eoy) x21.425.5 84.0%  
Price / Book Value ratio x3.43.1 111.4%  
Dividend payout %25.420.6 123.6%   
Avg Mkt Cap Rs m91,2711,264,650 7.2%   
No. of employees `0002.617.5 15.0%   
Total wages/salary Rs m3,14359,671 5.3%   
Avg. sales/employee Rs Th7,484.816,608.1 45.1%   
Avg. wages/employee Rs Th1,195.03,409.6 35.0%   
Avg. net profit/employee Rs Th1,369.11,833.8 74.7%   
INCOME DATA
Net Sales Rs m19,685290,659 6.8%  
Other income Rs m1,14310,255 11.1%   
Total revenues Rs m20,828300,914 6.9%   
Gross profit Rs m5,00363,076 7.9%  
Depreciation Rs m66317,533 3.8%   
Interest Rs m45,553 0.1%   
Profit before tax Rs m5,47950,246 10.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-12,144 0.0%   
Tax Rs m1,8786,009 31.3%   
Profit after tax Rs m3,60132,093 11.2%  
Gross profit margin %25.421.7 117.1%  
Effective tax rate %34.312.0 286.7%   
Net profit margin %18.311.0 165.7%  
BALANCE SHEET DATA
Current assets Rs m24,167310,692 7.8%   
Current liabilities Rs m9,544173,396 5.5%   
Net working cap to sales %74.347.2 157.3%  
Current ratio x2.51.8 141.3%  
Inventory Days Days5599 55.6%  
Debtors Days Days29112 25.7%  
Net fixed assets Rs m9,514232,477 4.1%   
Share capital Rs m4582,399 19.1%   
"Free" reserves Rs m26,375411,691 6.4%   
Net worth Rs m26,832414,091 6.5%   
Long term debt Rs m2515,226 0.2%   
Total assets Rs m36,900646,938 5.7%  
Interest coverage x1,305.510.0 12,991.5%   
Debt to equity ratio x00 2.5%  
Sales to assets ratio x0.50.4 118.7%   
Return on assets %9.85.8 167.9%  
Return on equity %13.47.8 173.1%  
Return on capital %20.410.2 200.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2266,025 0.0%   
Fx outflow Rs m1,48938,610 3.9%   
Net fx Rs m-1,46627,415 -5.3%   
CASH FLOW
From Operations Rs m3,31821,965 15.1%  
From Investments Rs m-2,383-6,813 35.0%  
From Financial Activity Rs m-1,104-27,305 4.0%  
Net Cashflow Rs m-169-8,442 2.0%  

Share Holding

Indian Promoters % 0.0 63.7 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 5.1 146.2%  
FIIs % 4.9 23.0 21.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 8.3 285.5%  
Shareholders   85,207 133,026 64.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   AUROBINDO PHARMA  DR. REDDYS LAB  ABBOTT INDIA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  

Compare PFIZER With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Continue Downtrend, Developments From the IPO Space, and Top Cues in Focus Today(Pre-Open)

On Tuesday, Indian share markets fell sharply during closing hours amid fears of rising crude oil prices and weakness in the rupee.

Related Views on News

SUN PHARMA Announces Quarterly Results (1QFY20); Net Profit Up 35.3% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, SUN PHARMA has posted a net profit of Rs 15 bn (up 35.3% YoY). Sales on the other hand came in at Rs 84 bn (up 15.9% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

SUN PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

Here's an analysis of the annual report of SUN PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 53.4% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, SUN PHARMA has posted a net profit of Rs 7 bn (down 53.4% YoY). Sales on the other hand came in at Rs 72 bn (up 2.7% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

More Views on News

Most Popular

Buying these Eight Stocks is Like Owning Your Own Business(Profit Hunter)

Sep 5, 2019

Everyone dreams of owning a business. Here is your chance.

7 Stocks to Buy in the Market Today(The 5 Minute Wrapup)

Sep 5, 2019

The stock market had a four-year bull run starting September 2013. Are we seeing a similar pattern now?

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Sep 17, 2019 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS